← Back to Search

Medical Device

Bovine Atelocollagen Skin Sensitization Test

N/A
Waitlist Available
Led By Peter Rullan, MD
Research Sponsored by AscentX Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 44 days
Awards & highlights
No Placebo-Only Group

Summary

This trial involves injecting cow-derived collagen into the skin of healthy adults to check for allergic reactions. The goal is to see if their immune system reacts negatively, which would indicate an allergy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~44 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 44 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hypersensitivity Evaluation

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Bovine Atelocollagen Skin Sensitization TestExperimental Treatment1 Intervention
Volunteer cohort tested for hypersensitivity towards intradermal injection of bovine atelocollagen.

Find a Location

Who is running the clinical trial?

AscentX Medical, Inc.Lead Sponsor
Peter Rullan, MDPrincipal InvestigatorDermatology Institute
~0 spots leftby Dec 2025